Article
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
Nature - 6 Sept 2001
Sharpless N E, Bardeesy N, Lee K H, Carrasco D, Castrillon D H, Aguirre A J, Wu E A, Horner J W, DePinho R A
Abstract excerpt
The cyclin-dependent kinase inhibitor p16INK4a can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer. Overlapping reading frames in the INK4A/ARF gene encode p16INK4a and a distinct tumour-suppressor protein, p19ARF (ref. 3). Here we describe the generation and characterization of a p16Ink4a-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.